Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Korea Exchange will review whether to delist biotech company SillaJen Inc. due to the indictment of embezzlement and breach of trust charges against its officials.
Company executives were suspected of avoiding massive losses by selling large amounts of stocks ahead of its regulatory filing in August 2019, using inside information that its key product Pexa-Vec failed clinical tests.
Prosecutors also suspect that former Sillajen CEO Moon Eun-sang acquired a stake in the company without any capital by taking over bonds with warrants.
Moon resigned last week as Sillajen CEO after a warrant of arrest was issued against him by the Seoul Southern District Court for using undisclosed information to sell SillaJen stocks and committing other irregularities.
The resignation was also perceived as a means to help SillaJen avoid a delisting.
Top managers’ alleged embezzlement can be a basis for a company to lose eligibility for listing on the stock market.
KOSDAQ has suspended trading of SillaJen stocks since May 4.
